Exploring the Use of Adult Stem Cells to Treat Back Pain

The Spine Institute uses an Adult Stem Cell Therapy that doesn’t require FDA approval to treat lumbar and cervical spine conditions resulting from injury or aging, and is also involved with an FDA clinical trial investigating the use of Adult Stem Cells.

Learn more about Adult Stem Cells.

Adult Stem Cell Therapy – No FDA Approval Required

The Spine Institute, in partnership with the Orthopedic Stem Cell Institute and SpineSmith®/Celling Technologies, uses adult mesenchymal stem cells that function to repair and replace damaged tissue. These stem cells are autologous – they are taken from an adult patient and returned to that same patient in a concentrated form to the damaged area. This type of treatment does not require FDA approval to administer.

For more information on Adult Stem Cells and the Orthopedic Stem Cell Institute, visit their website.

FDA Clinical Trial – Adult Stem Cell Therapy

Mesoblast has developed a process to immunoselect the mesenchymal precursor cells from adult bone marrow mononuclear cells and then expand these cells in culture to produce allogenic MPCs (NeoFuse™). These expanded cells have been shown to retain the mesenchymal cell capacity for differentiation into bone, cartilage, and adipose tissue in-vitro and to regenerate bone in-vivo.

If you are interested in participating in the Phase I disc repair study, please contact our research coordinator.

Click here for the inclusion/exclusion criteria for the Mesoblast (Stem Cell) Disc Repair Clinical Trial.

Click here for the inclusion/exclusion criteria for the Mesoblast (Stem Cell) Cervical Fusion Clinical Trial.

News About Adult Stem Cell Therapy

Stem Cell Shots into the Heart Could Stave Off Chest Pain

Orthopedic Stem Cells: Using Adult Stem Cells to Treat Back Pain

Colorado Doc Injects Stem Cells

Northern Colorado Spine Surgeon Successfully Performs First Minimally Invasive Lumbar Disc Procedure Using Adult Stem Cells